Bullish
Pfizer's stock rises 0.95% to $28.67 amid positive analyst outlook.
Pfizer's stock price increased by 0.95% to $28.67, reflecting positive investor sentiment. Analysts highlight the company's strong pipeline and cost-cutting initiatives as key growth drivers. Additionally, Envestnet Asset Management Inc. raised its stake in Pfizer by 1.8%, indicating confidence in the company's prospects.
Key points
- Analysts upgrade Pfizer to 'buy', citing low valuation and strong free cash flow.
- Envestnet Asset Management Inc. increases Pfizer stake by 1.8%.
- Pfizer plans November 3 analyst webcast; no new developments reported.
Sources
AI-generated from public news sources. Not financial advice.
